|
TRAM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.88498130835069E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.36397576461422E-14 |
| Normal-vs-Stage2 |
6.21158680047529E-12 |
| Normal-vs-Stage3 |
1.11022302462516E-15 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
9.674800E-01 |
| Stage1-vs-Stage3 |
1.328040E-01 |
| Stage1-vs-Stage4 |
5.18420000039654E-07 |
| Stage2-vs-Stage3 |
3.322800E-01 |
| Stage2-vs-Stage4 |
3.595400E-03 |
| Stage3-vs-Stage4 |
3.775700E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.88418203051333E-15 |
| Normal-vs-AfricanAmerican |
2.00920391435488E-11 |
| Normal-vs-Asian |
6.55031584528842E-14 |
| Caucasian-vs-AfricanAmerican |
8.621600E-01 |
| Caucasian-vs-Asian |
7.666200E-01 |
| AfricanAmerican-vs-Asian |
7.058000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.46549439250521E-14 |
| Normal-vs-Female |
4.10782519111308E-15 |
| Male-vs-Female |
7.025200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.22689999999482E-05 |
| Classical-VS-Follicular |
6.435800E-01 |
| Classical-VS-Other |
2.630400E-01 |
| Classical-VS-Normal |
1.71063163634244E-12 |
| Tall-VS-Follicular |
3.049600E-02 |
| Tall-VS-Other |
5.706200E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
6.231800E-01 |
| Follicular-VS-Normal |
3.02813329966511E-12 |
| Other-VS-Normal |
6.11499999999543E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63524749297039E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.402060E-03 |
|
|
